Peptides: who's using them and what's in them?
From Health Report · · 44 min
This plays from the publisher's own server. We do not host a copy.
Description
The popularity of peptides appears to be growing in Australia - what do we know about who is using them, what's in them and the risks?
A large study of Australians with Parkinson's disease finds links to certain pesticides and high-risk occupations.
For people with heart failure, there's a procedure that you can avoid with no ill-effect.
And an outbreak of diptheria across multiple states in Australia - how did this happen?
References
- Obesity and cardiovascular disease: A clinical consensus statement from the National Heart Foundation of Australia (https://www.heartfoundation.org.au/for-professionals/obesity-cvd-consensus-statement)
- Impact and Effectiveness of Australia's 2025 Hybrid RSV Immunisation Program: Results from the PAEDS-FluCAN Network (https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6395678)
- Diphtheria outbreak could be 'contained within months' but response criticised as too slow (https://www.abc.net.au/news/2026-05-22/diphtheria-outbreak-could-be-contained-within-months/106710434)
- Responding to injectable synthetic peptide use among young people: priorities for clinicians and public health (https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(26)00099-4/abstract)
- Insights from a cross-sectional population-based study of 10,929 Australians living with Parkinson's disease: risk factors, comorbidities, and sex differences (https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(26)00020-9/fulltext)
- Cardiac resynchronization therapy with or without atrioventricular node ablation in atrial fibrillation: the CAAN-AF trial (https://pubmed.ncbi.nlm.nih.gov/41985940/)